Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Journal of Extracellular Vesicles|July 2, 2016
Proteomics analysis of vesicles isolated from plasma and urine of prostate cancer patients using a multiplex, aptamer-based protein arrayJoanne Louise Welton, Paul Brennan, Mark Gurney, et al.
Haematologica|December 30, 2020
CD38 knockout natural killer cells expressing an affinity optimized CD38 chimeric antigen receptor successfully target acute myeloid leukemia with reduced effector cell fratricideMark Gurney, Arwen Stikvoort, Emma Nolan, et al.
Theranostics|May 1, 2019
Membrane Radiolabelling of Exosomes for Comparative Biodistribution Analysis in Immunocompetent and Immunodeficient Mice - A Novel and Universal ApproachFarid N Faruqu, Julie Tzu-Wen Wang, Lizhou Xu, et al.
Platelets|November 18, 2008
DG-041 inhibits the EP3 prostanoid receptor--a new target for inhibition of platelet function in atherothrombotic diseaseStan Heptinstall, David Iyu Espinosa, Panagiotis Manolopoulos, et al.
Bioorganic & Medicinal Chemistry Letters|March 23, 2010
1,7-Disubstituted oxyindoles are potent and selective EP(3) receptor antagonistsNian Zhou, Alexandre M Polozov, Matthew O'Connell, et al.
Scientific Reports|March 28, 2019
The putative tumour suppressor protein Latexin is secreted by prostate luminal cells and is downregulated in malignancyRobert I Seed, Alberto J Taurozzi, Daniel J Wilcock, et al.
Blood Advances|April 2, 2024
The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significanceMarissa Li, Anmol Baranwal, Mark Gurney, et al.
Cell Host & Microbe|March 11, 2008
Selective killing of nonreplicating mycobacteriaRuslana Bryk, Benjamin Gold, Aditya Venugopal, et al.
British Journal of Haematology|May 5, 2023
The clinical and molecular spectrum of ETV6 mutated myeloid neoplasmsMark Gurney, Ismahene Chekkaf, Anmol Baranwal, et al.
American Journal of Hematology|September 27, 2024
PHF6 mutations in chronic myelomonocytic leukemia identify a unique subset of patients with distinct phenotype and superior prognosisAyalew Tefferi, Saubia Fathima, Ali Khalid A Alsugair, et al.
Pageof 4